BackVera Therapeutics Overview

Vera Therapeutics Accounts Payable

Vera Therapeutics's accounts payable is $15M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$14.57M
10.76% YoYΔ $1.42M vs prior year quarter

Peer trimmed avg / median

Loading

Vera Therapeutics Accounts Payable History

Loading

Vera Therapeutics vs. peers: Accounts Payable Comparison

Loading

Vera Therapeutics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Vera Therapeutics (VERA) FAQ

As of the most recent data (June 2026), VERA shows a accounts payable of $15M. That compares with $13M in the prior-year period — up 10.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VERA's accounts payable is now $15M (was $13M) — a 10.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Vera Therapeutics is outperforming or lagging.

Tracking VERA's accounts payable over time shows whether Vera Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $15M That compares with $13M in the prior-year period — up 10.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Vera Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $15M) with ownership activity and broader fundamentals.

Vera Therapeutics's accounts payable is $15M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.